VIVO
Weill Cornell Medical College
Index
Log in
Search form
Home
People
Organizations
Research
Support
IMPAACT 2047; Phase II, Randomized Study of the Pharmacokinetics, Safety and Tolerability of High Dose Rifapentine given with Moxifloxacin for Tuberculosis during Pregnancy. Radiant-Moms Plus: Rifapentine in High Doses in Pregnancy with TB
Grant
Overview
date/time interval
December 1, 2024 - November 30, 2027
awarded by
Commonwealth Fund
administered by
Medicine-Global Health
sponsor award ID
UM1 AI068632
Affiliation
contributor
Mathad, Jyoti S.
Principal Investigator (Subaward)
2024 - 2025